Immunomodulating antibodies and drugs for the treatment of hematological malignancies.
about
Immunomodulation of Selective Naive T Cell Functions by p110δ Inactivation Improves the Outcome of Mismatched Cell Transplantation.CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications.Cancer cell-binding peptide fused Fc domain activates immune effector cells and blocks tumor growth.Combination strategies to enhance antitumor ADCC.Development of anticancer drugs based on the hallmarks of tumor cells.Boosting antibody-dependant cellular cytotoxicity against tumor cells with a CD137 stimulatory antibody.On the representation of cells in bone marrow pathology by a scalar field: propagation through serial sections, co-localization and spatial interaction analysis.
P2860
Q35973413-88AC6857-6996-4F5E-859D-BDD93F31BC47Q36204132-0DCD9BCC-3A4F-4D33-982C-7E61E41C70C1Q37689046-9BA36201-7A2D-42B7-9AD9-6192A56A0A76Q38014085-1B564AEA-AEDB-4E20-9D76-AAC910F840E2Q38182491-9E2C8FE4-FBB1-41EE-9038-5582C958D456Q41474839-515253DB-D22D-432C-8AEB-B8A71F5CC93FQ43045608-2ABAC92B-7EC5-416E-AEDD-FE96E46E40A2
P2860
Immunomodulating antibodies and drugs for the treatment of hematological malignancies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunomodulating antibodies and drugs for the treatment of hematological malignancies.
@en
Immunomodulating antibodies and drugs for the treatment of hematological malignancies.
@nl
type
label
Immunomodulating antibodies and drugs for the treatment of hematological malignancies.
@en
Immunomodulating antibodies and drugs for the treatment of hematological malignancies.
@nl
prefLabel
Immunomodulating antibodies and drugs for the treatment of hematological malignancies.
@en
Immunomodulating antibodies and drugs for the treatment of hematological malignancies.
@nl
P2093
P2860
P1476
Immunomodulating antibodies and drugs for the treatment of hematological malignancies.
@en
P2093
Holbrook Kohrt
Matthew J Goldstein
Roch Houot
Ronald Levy
P2860
P2888
P304
P356
10.1007/S10555-011-9274-3
P577
2011-03-01T00:00:00Z